+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human embryonic stem cell transplantation to repair the infarcted myocardium



Human embryonic stem cell transplantation to repair the infarcted myocardium



Heart 93(10): 1278-1284



To test the hypothesis that human embryonic stem cells (hESCs) can be guided to form new myocardium by transplantation into the normal or infarcted heart, and to assess the influence of hESC-derived cardiomyocytes (hESCMs) on cardiac function in a rat model of myocardial infarction (MI). Undifferentiated hESCs (0.5-1x10(6)), human embryoid bodies (hEBs) (4-8 days; 0.5-1x10(6)), 0.1 mm pieces of embryonic stem-derived beating myocardial tissue, and phosphate-buffered saline (control) were injected into the normal or infarcted myocardium of athymic nude rats (n = 58) by direct injection into the muscle or into preimplanted three-dimensional alginate scaffold. By 2-4 weeks after transplantation, heart sections were examined to detect the human cells and differentiation with fluorescent in situ hybridisation, using DNA probes specific for human sex chromosomes and HLA-DR or HLA-ABC immunostaining. Microscopic examination showed transplanted human cells in the normal, and to a lesser extent in the infarcted myocardium (7/7 vs 2/6; p<0.05). The transplanted hESCs and hEBs rarely created new vessels and did not form new myocardium. Transplantation of hESCM tissue into normal heart produced islands of disorganised myofibres, fibrosis and, in a single case, a teratoma. However, transplantation of hESCMs into the infarcted myocardium did prevent post-MI dysfunction and scar thinning. Undifferentiated hESCs and hEBs are not directed to form new myocardium after transplantation into normal or infarcted heart and may create teratoma. Nevertheless, this study shows that hESC-derived cardiomyocyte transplantation can attenuate post-MI scar thinning and left ventricular dysfunction.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 021148019

Download citation: RISBibTeXText

PMID: 17566061

DOI: 10.1136/hrt.2006.093161


Related references

Embryonic stem cell transplantation for repair of infarcted myocardium and functional improvement with long-term follow up. Circulation 104(17 Suppl.): II 288-II 289, 2001

Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm 7(12): 1852-1859, 2010

Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair. International Journal of Nanomedicine 9: 5203-5215, 2014

Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium. Biochemical and Biophysical Research Communications 340(2): 573-582, 2006

Successful transplantation of fetal cardiomyoblasts into the infarcted myocardium of rat A potential method for repair of infarcted myocardium. Circulation 92(8 Suppl. ): I50-I51, 1995

Successful transplantation of foetal cardiomyocytes into the infarcted myocardium of rat A potential method for repair of infarcted myocardium. European Heart Journal 17(ABSTR Suppl. ): 268, 1996

Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?. Circulation 94(9 Suppl.): Ii332-6, 1996

Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice. Sheng Li Xue Bao 57(6): 673-681, 2005

Cardiogenesis and angiogenesis in infarcted myocardium by intramyocardial transplantation of embryonic stem cells in mice. Circulation 104(17 Suppl.): II 270, 2001

May cell transplantation repair infarcted myocardium?. Zhonghua Yi Xue Za Zhi 84(16): 1332-1333, 2004

Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366(9490): 1005-1012, 2005

Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation 108(9): 1139-1145, 2003

Stem-cell repair of infarcted myocardium: ready for clinical application?. American Heart Hospital Journal 2(2): 100-106, 2004

Signaling factors in stem cell-mediated repair of infarcted myocardium. Journal of Molecular and Cellular Cardiology 39(2): 363-376, 2005